📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease (2023)

First Author: Ezquerro S

Attributed to: Interrogating ITGA11 signalling in rodent and human for targeted anti-fibrotic therapy in liver fibrosis. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ejendo/lvad071

PubMed Identifier: 37358209

Publication URI: http://europepmc.org/abstract/MED/37358209

Type: Journal Article/Review

Parent Publication: European Journal of Endocrinology

Issue: 1

ISSN: 0804-4643